Mays Cancer Center Annual Report Magazine
2020 issue
Center Selected for National Patient Care Program
The Mays Cancer Center was one of 10 institutions selected nationwide for the American Society of Clinical Oncology’s (ASCO) Quality Oncology Practice Initiative® and Quality Training Program Improvement Program.
CPRIT Awards $10.3 Million for Five Grants
A $10.3 million CPRIT award to the Mays Cancer Center included $6 million to recruit David Gius, MD, PhD, a breast cancer and radiation oncology researcher, and $2 million to recruit Peng Zhao, PhD, a liver cancer researcher. This award also included three grants to individual cancer researchers: Dmitri Ivanov, PhD; Mingjiang Xu, MD, PhD, and Luiz Penalva, PhD.
Research Reveals Role of Protein in Kidney Cancer
Dharam Kaushik, MD, and his research team confirmed the role of a certain protein in the development of high-grade kidney cancer. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-4 (Nox4) — often referred to as Nox4 — was found to concentrate in the nucleus of human kidney cancer cells.
Fighting Cancer Cells That Grow with Therapy
Daruka Mahadevan, MD, PhD, leader of hematology and medical oncology care at the Mays Cancer Center, co-authored a paper explaining that two cancer-causing genes, called c-Myc and BCL2, are operative in “double-hit” high-grade lymphomas, which are incurable.
Greetings from the Executive Director
Ruben A. Mesa, MD, FACP, executive director of the Mays Cancer Center, explains how the cancer center team sprang into action to respond to the pandemic. They did not waiver in their mission to fight cancer.
Special Thanks from the President
William L. Henrich, MD, MACP, UT Health San Antonio president, discusses his pride in watching the Mays Cancer Center continue to provide cancer diagnosis and treatment to patients during the COVID-19 pandemic.
Message from the Dean
Robert Hromas, MD, FACP, dean of the Long School of Medicine, offers his appreciation for all the healing hands and helpful hearts who work diligently to help patients who are battling cancer and their families.
Welcome from the Greehey Children’s Cancer Research Institute
Manjeet Rao, PhD, interim director of the Greehey Children's Cancer Research Institute, shares progress made at the institute during the pandemic. Researchers continue to develop drugs and drug combinations that are moving into clinical trials.
Mays Cancer Center Senior Leadership
The Senior Leadership at the Mays Cancer Center
Mays Cancer Center Scientific Program Leaders
The Scientific Program Leaders at the Mays Cancer Center
Mays Cancer Center Senior Clinical Leaders
The Senior Clinical Leaders at the Mays Cancer Center